Xiamen C&a;D engages in supply chain, real estate development, tourism and hotel, conference and exhibition, investment and other businesses.
Business Model: B2B
Revenue: $0
Employees: 5,001-10,000
Address:
City: Xiamen
State: Fujian
Zip:
Country: China
Xiamen C&a;D Co., Ltd is a state-owned enterprise in Xiamen City. Founded in December 1980, after more than 30 years of innovation and transformation, the company has developed into a large industrial investment enterprise group with a registered capital of 5 billion Yuan, an annual operating income of over 220 billion Yuan and total assets of more than 210 billion Yuan, ranking 362th among the Global Fortune 500 companies in 2018, 112th among the top 500 Chinese companies and 49th among the top 500 Chinese service companies. From now on, their Corporation will expand the investment to existing core businesses, properly increase the investment to current emerging industries, actively carry out the capital operation on other invested enterprises, and try to invest in some new fields. Moreover, they will combine traditional industry project with high-tech projects, industrial investment with strategic investment and risk investment, and independent investment operation with joint-venture cooperation, so as to urge the formation and upgrade of the core competitiveness in key fields, realize the big increase of investment gain and the appreciation of core business brands, and promote the stable development of their Corporation.
Contact Phone:
Contact Email:
Listed Exchange:
SSE
IPO Date:
6/16/1998
Ticker Symbol:
600153
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2017 | CGA | Angel Round | 437.8k |
1/2022 | Olam China | Series A | - |
11/2021 | Vulbox | Series D | 46.9M |
5/2020 | Novast | Venture Round | 0 |
1/2022 | Enzymaster | Series C | 47.4M |
6/2018 | Zongmu | Series C | - |
10/2022 | VectorBuilder | Series C | 57.6M |
12/2018 | Skylimit Entertainment Group | Series A | - |
1/2023 | Kuntian New Energy | Venture Round | 294.8M |
12/2021 | Chuanwazi | Series A | 0 |
12/2016 | Quna | Series C | 4.3M |
8/2018 | Meipian | Series B | 14.6M |
9/2021 | H.Extract | Series C | 0 |
10/2020 | Zhenkunxing | Series E | 315M |
7/2020 | Zongteng Network | Series C | 0 |
9/2022 | Jialichuang | Series B | 129.2M |
11/2017 | Yanjiyou | Series B | 18.1M |
5/2022 | Jingsil Intelligent | Series A | 0 |
1/2019 | Nanup | Series B | 29.1M |
5/2018 | Microidea Technology | Series B | 0 |
11/2020 | Asieris Pharmaceuticals | Series D | 0 |
10/2020 | Zhenkunhang | Series E | 0 |
6/2019 | Yingsheng Biology | Venture Round | 0 |
1/2023 | GenScript ProBio | Series C | 0 |
1/2021 | Oricell Therapeutics | Series A | 0 |
12/2022 | Hyseim | Seed Round | 13M |
6/2018 | Skylimit Entertainment Group | Seed Round | 15.4M |
5/2022 | Jingsil Intelligent | Series A | 0 |
12/2021 | Chuanwazi | Series A | 0 |
11/2021 | Vulbox | Series D | 0 |
9/2021 | H.Extract | Series C | 0 |
11/2020 | Asieris Pharmaceuticals | Series D | 0 |
10/2020 | Zhenkunxing | Series E | 0 |
10/2020 | Zhenkunhang | Series E | 0 |
7/2020 | Zongteng Network | Series C | 0 |
5/2020 | Novast | Venture Round | 0 |
6/2019 | Yingsheng Biology | Venture Round | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|---|---|
12/2019 | Innostic |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|